Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01291719 · ClinicalTrials.gov registry record · Phase 1
Insulin Balanced Infusion System
A Phase 1 study of Diabetes and Hyperglycemia, sponsored by Admetsys Corporation.
- Active
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT01291719 is a Phase 1 study of Diabetes and Hyperglycemia that is active but no longer recruiting, run by Admetsys Corporation. The registered enrollment target is 40 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01291719, a Phase 1 study of Diabetes and Hyperglycemia, is active but no longer recruiting, sponsored by Admetsys Corporation.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to study the use of a counterbalancing system of glucose and insulin infusion with frequent blood glucose monitoring and combined adaptive algorithm can produce tight glycemic control without hypoglycemia; study to develop a closed loop for use in intensive care units and surgery
Conditions Studied
Interventions
- DEVICE glucose and insulin infusions
Study Locations (1)
Florida
- 3113 Lawton Road - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2008-11 |
| Est. Completion | 2026-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01291719
The ClinicalTrials.gov registry entry for NCT01291719 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower). The listed sponsor is Admetsys Corporation, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which glucose and insulin infusions is the first listed.
NCT01291719 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT01291719 about?
NCT01291719 is a clinical study titled "Insulin Balanced Infusion System". The purpose of this study is to study the use of a counterbalancing system of glucose and insulin infusion with frequent blood glucose monitoring and combined adaptive algorithm can produce tight glycemic control without hypoglycemia; study to develop a closed loop for use in intensive care units an...
What is the current status of trial NCT01291719?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2008-11. Estimated completion is 2026-11.
What conditions does trial NCT01291719 study?
This clinical trial studies the following conditions: Diabetes, Hyperglycemia.
What interventions are being tested in trial NCT01291719?
The interventions under investigation include: glucose and insulin infusions (DEVICE).
Who is sponsoring clinical trial NCT01291719?
This trial is sponsored by Admetsys Corporation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01291719 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mitigating the Pro-inflammatory Phenotype of Obesity
RECRUITING · Phase 1
-
Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye
RECRUITING · Phase 1
-
Ability of a Tea Leaf Extracts Preparation to Slow Down Carbohydrate and Fat Absorption
COMPLETED · Phase 1
-
Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections
COMPLETED · Phase 1
-
Family Management of Childhood Diabetes Study
COMPLETED · Phase 1
-
Effectiveness of Adding Subcutaneous Long-acting Glargine to Insulin Drip Therapy Compared With Standard Insulin Drip Therapy
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.